Projects per year
Personal profile
Fingerprint
Dive into the research topics where Marija Balic is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 9 Finished
-
Biomarkers of putative cancer stem cells in adenocarcinoma of the lung identified by next generation sequencing
Tiran, V. (Principal investigator), Stanzer, S. (Co-investigator), Dandachi, N. (Co-investigator) & Balic, M. (Co-investigator)
1/10/14 → 30/11/16
Project: Research funding
-
Methylation analysis of circulating tumor cells and white blood cells in breast cancer patients
Dandachi, N. (Principal investigator), Benezeder, T. H. (Co-investigator), Kühberger, S. (Co-investigator), Balic, M. (Co-investigator), Neiss, J. M. (Co-investigator) & Reinisch, I. N. (Co-investigator)
1/09/13 → 31/08/16
Project: Research funding
-
Identification of breast cancer stem cell-associated non-coding ultraconserved genes and their clinical relevance for breast cancer patients
Pichler, M. (Principal investigator), Stiegelbauer, V. (Co-investigator), Cerk, S. A. (Co-investigator), Hasenleithner, S. (Co-investigator), Balic, M. (Co-investigator), Resel, M. (Co-investigator), Klocker, E. V. (Co-investigator), Ninaus, D. (Co-investigator) & Lembeck, A. L. (Co-investigator)
1/12/12 → 31/10/16
Project: Research funding
-
DISSEMINATING TUMOR CELLS_BREAST CANCER: Disseminating tumor cells in primary metastasized breast cancer patients undergoing surgery of primary tumor
Balic, M. (Principal investigator), Tiran, V. (Co-investigator), Stanzer, S. (Co-investigator), Dandachi, N. (Co-investigator), Roßmann, C. H. (Co-investigator) & Suppan, C. (Co-investigator)
1/09/11 → 30/06/16
Project: Research funding
-
ANREICHERUNG_BRUSTKREBSSTAMMZELLEN: Enrichment and Characterization of putative Breast Cancer Stem Cells
Stanzer, S. (Principal investigator), Balic, M. (Co-principal investigator), Dandachi, N. (Co-investigator), Strutz, J. (Co-investigator) & Weißenbacher, B. (Co-investigator)
1/10/10 → 31/01/13
Project: Research funding
-
A novel algae oil-based emulsion enhances chemotherapy outcome in human cancer models
Steiner-Zitzenbacher, B. (First author), Karner, C. (First author), Uellen, A., Holzer, V., Vejzovic, D., Balic, M., Szkandera, J., Liegl-Atzwanger, B. & Rinner, B. (Last author), Jul 2026, In: Prostaglandins Leukotrienes and Essential Fatty Acids. 209, p. 102745 18 p., 102745.Research output: Contribution to journal › Research article
-
HER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trial.
Singer, C., Koenig, F., Kacerovsky-Strobl, S., Danzinger, S., Brunner, C., Suppan, C., Deutschmann, C., Balic, M., Greil, R., Egle, D., de Azambuja, E., Di Cosimo, S., Choudhury, A. & Gnant, M., Feb 2026, In: Breast. 85, p. 104679 12 p., 104679.Research output: Contribution to journal › Research article
-
Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from Austria
Dobric, N. (First author), Hasenleithner, S., Suppan, C., Klocker, E. V., Hlauschek, D., Graf, R., Beichler, C., Albertini, C., Egle, D., Liu, D., Starzer, A., Bartsch, R., Moser, T., Rinnerthaler, G., Jost, P., Heitzer, E., Dandachi, N. & Balic, M., Apr 2026, In: ESMO Open. 11, 4, p. 106939 12 p., 106939.Research output: Contribution to journal › Research article
-
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.
El Kababji, S., Mitsakakis, N., Jonker, E., Beltran-Bless, A., Pond, G., Vandermeer, L., Radhakrishnan, D., Mosquera, L., Paterson, A., Shepherd, L., Chen, B., Barlow, W., Gralow, J., Savard, M., Fesl, C., Hlauschek, D., Balic, M., Rinnerthaler, G., Greil, R. & Gnant, M. & 2 others, , 5 Mar 2025, In: Journal of Medical Internet Research. 27, p. e66821 28 p., e66821.Research output: Contribution to journal › Research article
11 Citations (Web of Science) -
Circulating tumor DNA profiling of patients with metastatic luminal HER2-low and HER2-0 breast cancer via next-generation sequencing.
Dobri, N., Dandachi, N., Klocker, E. V., Suppan, C., Graf, R., Lazzeri, I., Albertini, C., Rinnerthaler, G., Starzer, A., Bartsch, R., Hasenleithner, S., Jost, P., Heitzer, E. & Balic, M., 1 Jun 2025, In: Journal of Clinical Oncology. 43, 16_SUPPL, 1 p., e13090.Research output: Contribution to journal › Conference abstract
-
Extended adjuvant (adj) neratinib in HER2+/HR+ early breast cancer (eBC) in clinical routine - interim analysis of the multinational, prospective, non-interventional study (NIS) ELEANOR (n=300)
Breitenstein, U. (Author), Wrobel, D. (Author), Guth, D. (Author), Zaiss, M. (Author), Terhaag, J. (Author), Zahn, M. (Author), Perlova-Griff, L. (Author), Distelrath, A. (Author), Wuerstlein, R. (Author), Apel, K. (Author), Deuerling, N. (Author), Vannier, C. (Author), Bartsch, R. (Author), Jackisch, C. (Author), Mueller, V. (Author), Schmidt, M. (Author), Balic, M. (Author), Rinnerthaler, G. (Author), Lueftner, D. (Author), Zaman, K. (Author), Schwitter, M. (Author) & Harbeck, N. (Author)
2025Activity: Talk, presentation or poster › Poster
-
Circulating tumor DNA profiling of patients with metastatic luminal HER2-low and HER2-0 breast cancer via next-generation sequencing.
Dobri, N. (Author), Dandachi, N. (Author), Klocker, E. V. (Author), Suppan, C. (Author), Graf, R. (Author), Lazzeri, I. (Author), Albertini, C. (Author), Rinnerthaler, G. (Author), Starzer, A. (Author), Bartsch, R. (Author), Hasenleithner, S. (Author), Jost, P. (Author), Heitzer, E. (Author) & Balic, M. (Author)
2025Activity: Talk, presentation or poster › Poster
-
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials
Wimmer, K. (Author), Hlauschek, D. (Author), Balic, M. (Author), Pfeiler, G. (Author), Greil, R. (Author), Singer, C. (Author), Halper, S. (Author), Steger, G. (Author), Suppan, C. (Author), Gampenrieder, S. (Author), Helfgott, R. (Author), Egle, D. (Author), Filipits, M. (Author), Jakesz, R. (Author), Sölkner, L. (Author), Fesl, C. (Author), Gnant, M. (Author) & Fitzal, F. (Author)
2025Activity: Talk, presentation or poster › Poster
-
Predictive role of baseline [18F]FDG PET/CT quantitative parameters for response to neoadjuvant treatment with atezolizumab, trastuzumab, pertuzumab and epirubicin in HER2-positive early breast cancer - a substudy of the ABCSG-52/ATHENE phase II trial
Beheshti, M. (Author), Rinnerthaler, G. (Author), Farbod, A. (Author), Hitzl, W. (Author), Egle, D. (Author), Gampenrieder, S. (Author), Bartsch, R. (Author), Balic, M. (Author), Greil, R. (Author), Gnant, M. (Author) & Pirich, C. (Author)
2024Activity: Talk, presentation or poster › Poster
-
ctDNA profiling of HR+/HER2-low and HR+/HER2-0 metastatic breast cancer patients.
Dobrić, N. (Author) & Balic, M. (Author)
2024Activity: Talk, presentation or poster › Poster
Prizes
Thesis
-
Disseminating breast cancer stem cells and their molecular characterization
Balic, M. (Author), Samonigg, H. (Supervisor) & Speicher, M. (Supervisor), 2014Student thesis: Doctoral thesis